Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20200328046886N6
IRCT20200328046886N6
Recruiting
Phase 2

Evaluation of the efficacy and safety of colchicine in the prevention for post-CABG atrial fibrillation: a randomized double-blind placebo- controlled trial

Mazandaran University of Medical Sciences0 sites172 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAtrial Fibrillation.Unspecified atrial fibrillationI48.91

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Atrial Fibrillation.
Sponsor
Mazandaran University of Medical Sciences
Enrollment
172
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patient between 18\_80 years old
  • •Patient with CAD and candidate for CABG

Exclusion Criteria

  • •Preoperative AF
  • •Patients with pacemakers
  • •Patient with Clcr\<30ml/min
  • •Severe hepatic insufficiency or transaminase level more than 3 times higher than normal
  • •Breastfeeding or pregnancy
  • •Colchicine intolerance or allergy
  • •Lack of patients consent to participate in study
  • •Presences of sick Sinus syndrom
  • •Previous cardiac rhythm disorder,conduction blocks of any degree
  • •Co administration with strong pgp and 3A4 inhibitors (voiconazol,ketoconazole,fluconazole,itraconazole,clarithromycin,etc.)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Efficacy of Colchicine in Treatment of Covid-19Covid 19.Coronavirus as the cause of diseases classified elsewhereB97.2
IRCT20201229049872N1Artesh University of Medical Sciences80
Completed
Phase 2
Colchicine in combination with infliximb compared with infliximb in the treatment of patients with Covidian 19COVID-19.COVID-19, virus identifiedU07.1
IRCT20200325046854N2Iran University of Medical Sciences70
Recruiting
Phase 2
Effect of Colchicine on aphthous ulceration.Aphthous.Recurrent oral aphthaeK12.0
IRCT20160920029889N4Mazandaran University of Medical Sciences10
Recruiting
Phase 3
Evaluation of colchicine in treatment of coronavirusPulmonary infection of COVD19.Coronavirus infection, unspecifiedB34.2
IRCT20200418047126N1Ardabil University of Medical Sciences100
Active, not recruiting
Phase 1
Evaluation of the efficacy of colchicine with and without betamethasone mouthwash in the management of recurrent aphthous stomatitis - ART1Recurrent aphthous stomatitis (RAS)
EUCTR2006-003327-36-GBGuy's & St Thomas' NHS Foundation Trust136